PMA is a distinct, highly symptomatic, and exacerbation-prone asthma phenotype distinguished by aspirin sensitivity, less atopy (lower IgE level), and lower forced vital capacity compared to traditional allergic asthma. This evidence concerns the gene IGHE and asthma.